SCHEMBL7805184

SCHEMBL7805184

CCn1[c]nc2cc(OC)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
POLB P06746 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
RPS6KA5 O75582 1/20 0.40
FGFR1 P11362 4/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HTT P42858 1/20 0.39
MAPT P10636 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
NQO2 P16083 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
GRIK2 Q13002 3/20 0.38
GRIK1 P39086 2/20 0.38
PTGER4 P35408 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7815068 0.89 TDP1 (0.47) TDP1POLBNPSR1RPS6KA5FGFR1
SCHEMBL7821616 0.87 TDP1 (0.44) TDP1POLBNPSR1ALDH1A1SMN1; SMN2
SCHEMBL7814439 0.83 TDP1 (0.41) TDP1POLBFGFR1ALDH1A1SMN1; SMN2
SCHEMBL11227007 0.81 ALDH1A1 (0.55) POLBNPSR1FGFR1ALDH1A1SMN1; SMN2
SCHEMBL3652546 0.78 TDP1 (0.44) TDP1POLBFGFR1ALDH1A1SMN1; SMN2
SCHEMBL17187279 0.77 KDM4E (0.39) RPS6KA5ALDH1A1HTTMAPTKDM4E
SCHEMBL27787868 0.77 ALDH1A1 (0.34) NPSR1ALDH1A1SMN1; SMN2HTTMAPT
SCHEMBL5982432 0.77 PGK1 (0.39) TDP1FGFR1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL7804842 0.76 DYRK1A (0.42) TDP1POLBNPSR1ALDH1A1SMN1; SMN2
SCHEMBL7811008 0.74 TDP1 (0.41) TDP1POLBFGFR1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed